Literature DB >> 1953716

Timing and role of p53 gene mutation in the recurrence of glioma.

Y Hayashi1, J Yamashita, K Yamaguchi.   

Abstract

Recently a 17p deletion and p53 gene mutations were reported in human gliomas, but the relationship of the timing of p53 gene mutation and oncogenesis of glioma is still obscure. We examined eight pairs of primary and recurrent gliomas. Four of eight had a histological malignant transformation. In the group with malignant transformation, three out of four pairs had a mutation in the p53 gene only in recurrence. None of the mutations in either primary or recurrent glioma was detected in the group with no histological change. All point mutations occurred within the evolutionarily conserved regions. This suggests that the p53 mutations occurred during the progression and were important in the malignant transformation in the some kinds of gliomas.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1953716     DOI: 10.1016/s0006-291x(05)81186-6

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  10 in total

1.  Establishment of two glioma cell lines from two surgical specimens obtained at different times from the same individual.

Authors:  K Onda; S Nagai; R Tanaka; K Morii; J I Yoshimura; I Tsumanuma; T Kumanishi
Journal:  J Neurooncol       Date:  1999-02       Impact factor: 4.130

2.  Short fluorodeoxyuridine exposure of different human glioblastoma lines induces high-level accumulation of S-phase cells that avidly incorporate 125I-iododeoxyuridine.

Authors:  Florence Perillo-Adamer; Angelika Bischof Delaloye; Céline S Genton; Andreas O Schaffland; Yves M Dupertuis; Franz Buchegger
Journal:  Eur J Nucl Med Mol Imaging       Date:  2006-02-01       Impact factor: 9.236

Review 3.  Basic fibroblast growth factor and fibroblast growth factor receptor I are implicated in the growth of human astrocytomas.

Authors:  R S Morrison; F Yamaguchi; H Saya; J M Bruner; A M Yahanda; L A Donehower; M Berger
Journal:  J Neurooncol       Date:  1994       Impact factor: 4.130

4.  Aberrant p53 expression in astrocytic neoplasms of the brain: association with proliferation.

Authors:  H Haapasalo; J Isola; P Sallinen; H Kalimo; H Helin; I Rantala
Journal:  Am J Pathol       Date:  1993-05       Impact factor: 4.307

5.  Distribution of p53 protein expression in gliosarcomas: an immunohistochemical study.

Authors:  S Albrecht; J H Connelly; J M Bruner
Journal:  Acta Neuropathol       Date:  1993       Impact factor: 17.088

6.  Single cell monitoring of growth arrest and morphological changes induced by transfer of wild-type p53 alleles to glioblastoma cells.

Authors:  E G Van Meir; K Roemer; A C Diserens; T Kikuchi; S A Rempel; M Haas; H J Huang; T Friedmann; N de Tribolet; W K Cavenee
Journal:  Proc Natl Acad Sci U S A       Date:  1995-02-14       Impact factor: 11.205

7.  Ubiquitin ligase RNF5 serves an important role in the development of human glioma.

Authors:  Yong Gao; Chengmin Xuan; Mingwei Jin; Qi An; Baobiao Zhuo; Xincheng Chen; Lei Wang; Yuan Wang; Qingzeng Sun; Yingchun Shi
Journal:  Oncol Lett       Date:  2019-09-04       Impact factor: 2.967

8.  Mutation of the endogenous p53 gene in cells transformed by HPV-16 E7 and EJ c-ras confers a growth advantage involving an autocrine mechanism.

Authors:  J W Peacock; S Benchimol
Journal:  EMBO J       Date:  1994-03-01       Impact factor: 11.598

9.  p53 protein in low-grade astrocytomas: a study with long-term follow-up.

Authors:  P Iuzzolino; C Ghimenton; A Nicolato; F Giorgiutti; P Fina; C Doglioni; M Barbareschi
Journal:  Br J Cancer       Date:  1994-03       Impact factor: 7.640

10.  Diagnostic and clinical relevance of the autophago-lysosomal network in human gliomas.

Authors:  Lukas Jennewein; Michael W Ronellenfitsch; Patrick Antonietti; Elena I Ilina; Jennifer Jung; Daniela Stadel; Lisa-Marie Flohr; Jenny Zinke; Janusz von Renesse; Ulrich Drott; Peter Baumgarten; Anne K Braczynski; Cornelia Penski; Michael C Burger; Jean-Philippe Theurillat; Joachim P Steinbach; Karl-Heinz Plate; Ivan Dikic; Simone Fulda; Christian Brandts; Donat Kögel; Christian Behrends; Patrick N Harter; Michel Mittelbronn
Journal:  Oncotarget       Date:  2016-04-12
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.